DocuSign's AI Turn Is Real. The Stock Price Now Assumes It Already Worked.

DocuSign's AI turn looks real. The stock price now assumes it's already worked.

A year ago the market treated DocuSign as yesterday's software. The e-signature pioneer had gone from 40% growth to high single digits, its stock had halved from its highs, and the only debate was how much further the multiple would compress. Then the last four months happened: DOCU is up roughly 46% over the past four months, and still climbing after yesterday's fiscal-second-quarter print, when the company beat on profit, raised full-year guidance, and watched shares jump about 7% after hours. The question now is not whether DocuSign is fixing itself — the evidence says it is — but whether the rally has already bought the outcome it is trading on.

The quarter that set the stock moving was genuinely good. Revenue rose 9% to $875.7 million, an acceleration of about a point after stripping out currency and digital add-ons. Non-GAAP operating margin hit 31.6%, up 180 basis points, and free cash flow was $296 million at a 34% margin. DocuSign now prints roughly $1.2 billion of free cash flow a year, sits on $973 million of cash and investments with no debt, and is buying back stock at a pace that cut its diluted share count 8% year over year. That is a mature, improving, cash-generative business — the opposite of the broken-saas caricature the price used to imply.

The number that matters most, though, is in the transition narrative. DocuSign is repositioning itself from e-signature to IAM — Intelligent Agreement Management — an AI-native platform that ingests, analyzes, and acts on the full content of agreements rather than just the signature line. In the quarter, IAM grew to 15.1% of total annual recurring revenue, up from 12.6% at the start of the quarter and 10.8% six months earlier. Management guides that mix to 18% to 19% by the end of the fiscal year, and it is on that trajectory that it raised full-year ARR growth guidance to 8.5% to 9%. After years of deceleration, that specific, disclosed metric — AI services becoming a bigger slice of contracted revenue, quarter after quarter — is the closest thing to proof that the AI pitch is converting into paid demand rather than staying on a slide deck.

Which is exactly why the easy part of this trade is over.

Here is the tension the market pushed the stock to confront. The reported 9% growth includes 1.3 points of currency tailwind; on an organic constant-currency basis DocuSign is growing in the high single digits. Even the bullish IAM trajectory only lifts total ARR growth to 8.5% to 9% this year. Yet the stock now trades at roughly 40 times trailing earnings, about 32 times EBITDA, and near 4 times sales — a premium over the 17.8 times earnings and 12 times EBITDA that Dropbox carries. The multiple has stopped pricing in the risk of failure and started pricing in a re-acceleration that the reported numbers do not show yet. The selloff that once made the reset interesting was collected on the way up.

Two cautions keep the bullish case from being a slam dunk, and both show up in the same quarter's disclosures. First, the growth engine still relies on patience: direct-customer dollar net retention is roughly 103%, better than a year ago but well short of the 110%-plus that used to justify software multiples, and the 18% to 19% year-end IAM target requires adding nearly four points of mix in two quarters. Second, DocuSign stopped reporting billings when the fiscal year turned over — it now guides only to ARR growth. A company asking investors to pay for a re-acceleration removed one of the few leading indicators that would verify it in between report dates. That is not a red flag on the quarter, but it is a reason to demand the proof at the next two prints rather than extrapolate today's.

This is the point where a good company and a good stock diverge, and the honest answer is that the first screen of this rally was the opportunity, not the ninth-figure one. The operating evidence has confirmed the thesis the market first bought at $40: the AI transition is real, margins and cash flow are expanding, and the balance sheet can fund it. But at this multiple, the investment now stands on the narrower claim that IAM keeps climbing to 18% to 19% of ARR and that constant-currency growth holds above 8% through the fiscal year — two to four quarters of proof, every one of them falsifiable. If the next prints deliver that, the premium is earned. If the mix stalls in the high teens or organic growth drifts back toward 7%, the stock has further to correct than the operating story does.

For a new position, the cheap-enough reset has already been taken. DocuSign is now a hold-and-verify situation: own it if you already rode the move, and for everyone else, let the next two quarters' IAM mix and ARR growth pay for the multiple before you do.